Research ArticleClinical Studies
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study
BARTOSZ PULA, ELZBIETA ISKIERKA-JAZDZEWSKA, MONIKA DLUGOSZ-DANECKA, AGNIESZKA SZYMCZYK, MAREK HUS, AGNIESZKA SZEREMET, JOANNA DROZD-SOKOLOWSKA, ANNA WASZCZUK-GAJDA, JAN M. ZAUCHA, JADWIGA HOLOJDA, WERONIKA PISZCZEK, PAWEL STECKIEWICZ, MALGORZATA WOJCIECHOWSKA, MICHAL OSOWIECKI, WANDA KNOPINSKA-POSLUSZNY, MAREK DUDZINSKI, DARIA ZAWIRSKA, EDYTA SUBOCZ, JANUSZ HALKA, ANDRZEJ PLUTA, RYSZARD WICHARY, BEATA KUMIEGA, BOZENA K. BUDZISZEWSKA, WOJCIECH JURCZAK, EWA LECH-MARANDA, KRZYSZTOF GIANNOPOULOS, TADEUSZ ROBAK and KRZYSZTOF JAMROZIAK
Anticancer Research July 2020, 40 (7) 4059-4066; DOI: https://doi.org/10.21873/anticanres.14403
BARTOSZ PULA
1Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
ELZBIETA ISKIERKA-JAZDZEWSKA
2Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
MONIKA DLUGOSZ-DANECKA
3Department of Clinical Oncology, Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland
AGNIESZKA SZYMCZYK
4Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
MAREK HUS
4Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
AGNIESZKA SZEREMET
5Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland
JOANNA DROZD-SOKOLOWSKA
6Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
ANNA WASZCZUK-GAJDA
6Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
JAN M. ZAUCHA
7Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
JADWIGA HOLOJDA
8Department of Hematology, Specialist District Hospital, Legnica, Poland
WERONIKA PISZCZEK
9Department of Hematology, Copernicus Hospital, Torun, Poland
PAWEL STECKIEWICZ
10Department of Hematology, Holycross Cancer Center, Kielce, Poland
MALGORZATA WOJCIECHOWSKA
11Department of Hematology, Specialist District Hospital, Olsztyn, Poland
MICHAL OSOWIECKI
12Department of Lymphoid Malignancies, Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland
WANDA KNOPINSKA-POSLUSZNY
13Department of Hematology, Independent Public Health Care of the Ministry of the Internal Affairs with the Oncology Centre, Olsztyn, Poland
MAREK DUDZINSKI
14Department of Hematology, Specialist District Hospital, Rzeszow, Poland
DARIA ZAWIRSKA
15Department of Hematology, Jagiellonian University, Krakow, Poland
EDYTA SUBOCZ
16Department of Hematology, Military Institute of Medicine, Warsaw, Poland
JANUSZ HALKA
16Department of Hematology, Military Institute of Medicine, Warsaw, Poland
ANDRZEJ PLUTA
17Department of Hematological Oncology, Regional Specialist Hospital, Brzozow, Poland
RYSZARD WICHARY
18Department of Hematology and Bone Marrow Transplantation, Katowice Medical Department, Silesian Medical University, Katowice, Poland
BEATA KUMIEGA
19Department of Hematology, Specialist District Hospital, Nowy Sacz, Poland
BOZENA K. BUDZISZEWSKA
1Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
WOJCIECH JURCZAK
3Department of Clinical Oncology, Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland
EWA LECH-MARANDA
20Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
21Department of Hematology and Transfusion Medicine, Centre of Postgraduate Medical Education, Warsaw, Poland
KRZYSZTOF GIANNOPOULOS
22Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
TADEUSZ ROBAK
2Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
KRZYSZTOF JAMROZIAK
1Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
In this issue
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study
BARTOSZ PULA, ELZBIETA ISKIERKA-JAZDZEWSKA, MONIKA DLUGOSZ-DANECKA, AGNIESZKA SZYMCZYK, MAREK HUS, AGNIESZKA SZEREMET, JOANNA DROZD-SOKOLOWSKA, ANNA WASZCZUK-GAJDA, JAN M. ZAUCHA, JADWIGA HOLOJDA, WERONIKA PISZCZEK, PAWEL STECKIEWICZ, MALGORZATA WOJCIECHOWSKA, MICHAL OSOWIECKI, WANDA KNOPINSKA-POSLUSZNY, MAREK DUDZINSKI, DARIA ZAWIRSKA, EDYTA SUBOCZ, JANUSZ HALKA, ANDRZEJ PLUTA, RYSZARD WICHARY, BEATA KUMIEGA, BOZENA K. BUDZISZEWSKA, WOJCIECH JURCZAK, EWA LECH-MARANDA, KRZYSZTOF GIANNOPOULOS, TADEUSZ ROBAK, KRZYSZTOF JAMROZIAK
Anticancer Research Jul 2020, 40 (7) 4059-4066; DOI: 10.21873/anticanres.14403
Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study
BARTOSZ PULA, ELZBIETA ISKIERKA-JAZDZEWSKA, MONIKA DLUGOSZ-DANECKA, AGNIESZKA SZYMCZYK, MAREK HUS, AGNIESZKA SZEREMET, JOANNA DROZD-SOKOLOWSKA, ANNA WASZCZUK-GAJDA, JAN M. ZAUCHA, JADWIGA HOLOJDA, WERONIKA PISZCZEK, PAWEL STECKIEWICZ, MALGORZATA WOJCIECHOWSKA, MICHAL OSOWIECKI, WANDA KNOPINSKA-POSLUSZNY, MAREK DUDZINSKI, DARIA ZAWIRSKA, EDYTA SUBOCZ, JANUSZ HALKA, ANDRZEJ PLUTA, RYSZARD WICHARY, BEATA KUMIEGA, BOZENA K. BUDZISZEWSKA, WOJCIECH JURCZAK, EWA LECH-MARANDA, KRZYSZTOF GIANNOPOULOS, TADEUSZ ROBAK, KRZYSZTOF JAMROZIAK
Anticancer Research Jul 2020, 40 (7) 4059-4066; DOI: 10.21873/anticanres.14403
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.